Back to search

Peptide record

TPDB15163

Antibacterial Toxicity standard
7 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB15163
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
dbAMP DRAMP Peptipedia
standard
No
A 7-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from dbAMP, DRAMP, and Peptipedia, with an available 3D structural model.
Sequence
LLKWLKK
Physicochemical Analysis
C47H81N11O8
ARNDCEQGHIMFPSTYV
LK
928.23
10.84
3
0
4
+3
-0.56
-0.171
167.14
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
5500
592.53
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
3
L
3
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 3 K: 3 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
7
C47H81N11O8
928.23
10.84
+3
-0.56
-0.171
Evidence Records 10 records
Evidence 1 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

B. subtilis ATCC 6633

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against Gram+ B. subtilis ATCC 6633 (MIC 100 ug/ml), S.aureus ATCC 6538p (MIC 200 ug/ml), S.epidermis ATCC 12228 (MIC >200 ug/ml), M. luteus
Evidence 2 Activity

Activity

MIC
Antibacterial
200 µg/mL

Target

S.aureus ATCC 6538p

Source & Reference

dbAMP DRAMP

Other

active against Gram+ B. subtilis ATCC 6633 (MIC 100 ug/ml), S.aureus ATCC 6538p (MIC 200 ug/ml), S.epidermis ATCC 12228 (MIC >200 ug/ml), M. luteus ATCC 10240 (MIC 25 ug/ml), Gram- E.co
Evidence 3 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

S.epidermis ATCC 12228

Source & Reference

dbAMP DRAMP

Other

against Gram+ B. subtilis ATCC 6633 (MIC 100 ug/ml), S.aureus ATCC 6538p (MIC 200 ug/ml), S.epidermis ATCC 12228 (MIC >200 ug/ml), M. luteus ATCC 10240 (MIC 25 ug/ml), Gram- E.coli ATCC 25922 (MIC >200 ug/ml), S. dysent
Evidence 4 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

M. luteus ATCC 10240

Source & Reference

dbAMP DRAMP

Other

100 ug/ml), S.aureus ATCC 6538p (MIC 200 ug/ml), S.epidermis ATCC 12228 (MIC >200 ug/ml), M. luteus ATCC 10240 (MIC 25 ug/ml), Gram- E.coli ATCC 25922 (MIC >200 ug/ml), S. dysentariae ATCC 9752 (MIC 100 ug/ml), S.ty
Evidence 5 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

E.coli ATCC 25922

Source & Reference

dbAMP DRAMP

Other

/ml), S.epidermis ATCC 12228 (MIC >200 ug/ml), M. luteus ATCC 10240 (MIC 25 ug/ml), Gram- E.coli ATCC 25922 (MIC >200 ug/ml), S. dysentariae ATCC 9752 (MIC 100 ug/ml), S.typhimorium ATCC 14028 (MIC >200 ug/ml), K.p
Evidence 6 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

S. dysentariae ATCC 9752

Source & Reference

dbAMP DRAMP

Other

00 ug/ml), M. luteus ATCC 10240 (MIC 25 ug/ml), Gram- E.coli ATCC 25922 (MIC >200 ug/ml), S. dysentariae ATCC 9752 (MIC 100 ug/ml), S.typhimorium ATCC 14028 (MIC >200 ug/ml), K.pneumoniae ATCC 10031 (MIC >200 ug/ml), and
Evidence 7 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

S.typhimorium ATCC 14028

Source & Reference

dbAMP DRAMP

Other

/ml), Gram- E.coli ATCC 25922 (MIC >200 ug/ml), S. dysentariae ATCC 9752 (MIC 100 ug/ml), S.typhimorium ATCC 14028 (MIC >200 ug/ml), K.pneumoniae ATCC 10031 (MIC >200 ug/ml), and P.aeruginosa ATCC 27853 (MIC >200 ug/ml).
Evidence 8 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

K.pneumoniae ATCC 10031

Source & Reference

dbAMP DRAMP

Other

ml), S. dysentariae ATCC 9752 (MIC 100 ug/ml), S.typhimorium ATCC 14028 (MIC >200 ug/ml), K.pneumoniae ATCC 10031 (MIC >200 ug/ml), and P.aeruginosa ATCC 27853 (MIC >200 ug/ml).
Evidence 9 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

P.aeruginosa ATCC 27853

Source & Reference

dbAMP DRAMP

Other

S.typhimorium ATCC 14028 (MIC >200 ug/ml), K.pneumoniae ATCC 10031 (MIC >200 ug/ml), and P.aeruginosa ATCC 27853 (MIC >200 ug/ml).
Evidence 10 Activity

Activity

5% Hemolysis
Toxicity
200 µg/mL
Hemolytic Cytotoxic
5% Hemolysis | 200 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. | J Pept Sci | 2009